Donga ST announced that superbacteria target antibiotics 'Tedizolid’ got approval of U.S. FDA Anti -Infective Drugs Advisory Committee

On Apr 1, Donga ST announced that superbacteria target antibiotics 'Tedizolid (brand name SIVEXTRO ™) of which they exported techniques to Trius Therapeutics, got approval of U.S. FDA Anti -Infective Drugs Advisory Committee.

It was reported that on March 31 (U.S. local time), all 14 members of U.S. FDA Anti -Infective Drugs Advisory Committee supported the approval of 'SIVEXTRO', and they pla...